Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022

$0.161
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0125 (-7.20%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can watch OTLKW and buy or sell other stocks, options, and ETFs commission-free!

About OTLKW

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ. The listed name for OTLKW is Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022.

CEO
Lawrence A. Kenyon, CPA
Employees
Headquarters
South Brunswick, New Jersey
Founded
2010
Market Cap
Price-Earnings Ratio
Dividend Yield
Average Volume
18.37K
High Today
$0.1735
Low Today
$0.16
Open Price
$0.1735
Volume
14.95K
52 Week High
$0.3489
52 Week Low
$0.0208

Collections

You May Also Like